Literature DB >> 1677552

Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental?

H S Nelson, S J Szefler, R J Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1677552     DOI： 10.1164/ajrccm/144.2.249

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  6 in total

Review 1.  Asthmatic drugs and competitive sport. An update.

Authors:  A R Morton; K D Fitch
Journal:  Sports Med       Date:  1992-10       Impact factor: 11.136

Review 2.  Long- versus short-acting beta 2-agonists. Implications for drug therapy.

Authors:  L P Boulet
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

3.  Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.

Authors:  A H Anis; L D Lynd; X H Wang; G King; J J Spinelli; M Fitzgerald; T Bai; P Paré
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

Review 4.  Exercise-induced asthma and anaphylaxis.

Authors:  D O Hough; K L Dec
Journal:  Sports Med       Date:  1994-09       Impact factor: 11.136

Review 5.  Beta 2 adrenergic receptors in asthma: a current perspective.

Authors:  T R Bai
Journal:  Lung       Date:  1992       Impact factor: 2.584

Review 6.  The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

Authors:  M R Sears; D R Taylor
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.